← Back to catalogue

Anti-Gfap

FDA UDI

Class I (US FDA UDI)

by Biogenex Laboratories, Inc.

Identity

Trade Name
ANTI-GFAP FDA UDI
Generic Name
Glial fibrillary acidic protein (GFAP) IVD, antibody FDA UDI
Model / Reference
PU020-5UP FDA UDI

Identifiers

Catalog Number
PU020-5UP FDA UDI
Primary DI / UDI-DI
00810119674364 FDA UDI
FDA Product Code
NJT FDA UDI
GMDN Term
Glial fibrillary acidic protein (GFAP) IVD, antibody FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.1860 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 0.5 Milliliter FDA UDI

Category: Glial fibrillary acidic protein (GFAP) IVD, antibody

Anti-Gfap by Biogenex Laboratories, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Glial fibrillary acidic protein (GFAP) IVD, antibody.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI b5a7b71e-b432-46d4-926b-fe09c916bce6 36 fields · synced Jun 1, 2026